Modelling and Simulation in the Development and use of Anti-Cancer Agents: An Underused Tool?

Author： Rombout Ferdinand   Aarons Leon   Karlsson Mats   Man Anthony   Mentré France   Nygren Peter   Racine Amy   Schaefer Hans   Steimer Jean-Louis   Troconiz Iñaki   van Peer Achiel  

Publisher： Springer Publishing Company

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.31, Iss.6, 2004-12, pp. : 419-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 1999-2013

Bentham Science Publishers

Access to resources Recommend Favorite

Rebeccamycin analogues as anti-cancer agents

By Prudhomme M.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 2, 2003-02 ,pp. : 123-140

Elsevier

Access to resources Recommend Favorite

Antibodies and their Fragments as Anti-Cancer Agents

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 363-378

Bentham Science Publishers

Access to resources Recommend Favorite

Bradykinin Antagonists as Anti-Cancer Agents

By  

Current Pharmaceutical Design, Vol. 9, Iss. 25, 2003-10 ,pp. : 2036-2042

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite